Head-to-head · WeighScore
MadeMed vs Prime Doctor RX
By GLP-1 ScorecardUpdated
Score comparison
MadeMed has the higher recorded score — 80.4/100 to 73/100.
MadeMed grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MadeMed advertises all-dose pricing across 30-, 90- and 360-day purchases, with a consultation-fee conflict to resolve before prepaying.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | MadeMed | Prime Doctor RX |
|---|---|---|
| WeighScore | 80.4/100 | 73/100 |
| Grade | B− | C |
| Site position | #23 | #82 |
| Semaglutide | $179 every 30 days; $483/90 days or $1,718/360 days ($143.17 equivalent per 30 days); consultation fees and usable supply require confirmation | $249 every 4 weeks (thirteen charges a year, not twelve) |
| Tirzepatide | Injection or sublingual: $249 every 30 days; $672/90 days or $2,390/360 days ($199.17 equivalent per 30 days); final fees and supply unverified | $339 every 4 weeks (thirteen charges a year, not twelve) |
| Coverage | Confirm selected treatment/state: sublingual tirzepatide FAQ lists 40 states; current injection-state map unverified | Not publicly listed |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #23 · B−
Strengths
- Public selectors show full charges for 30-, 90- and 360-day plans across the listed GLP-1 products
- Advertises the same pricing across doses, ongoing clinical messaging and included injection supplies
- Current terms name MDI Medical Group PC and four partner pharmacy brands
- A 30-day purchase is advertised alongside the larger prepaid options
What to consider
- Lowest advertised equivalents require $1,718/$2,390 360-day billing plans; terms reject prorated refunds
- Product pages list $20/$30 consultation fees while How It Works says consultation is included and ineligible payments are refunded in full
- The forty-state claim is specific to sublingual tirzepatide; an injection-state map was not established
- Assigned clinician/pharmacy branch, patient lab costs, final first debit and usable prescription supply remain unresolved
Site position #82 · C
Strengths
- The full ladder for all three weight-loss products and for TRT sits on the homepage before any intake
- The asterisk is honored: every card's footnote says the starting price is the 52-week prepay, in full
- The four-week shipping cycle is disclosed in that same footnote rather than left to a bank statement
- Names OpenLoop Health as the group providing telehealth evaluation and prescribing
- Hormone-care initial labs are priced at $50 rather than left unstated
What to consider
- Its own arithmetic proves the 28-day cycle — $3,497 divided by thirteen is exactly $269, and nothing on the page divides cleanly by calendar months
- A year of month-to-month tirzepatide therefore costs $4,407, not the $4,068 that per-month pricing implies
- The $269 and $179 headlines are 52-week prepays; month to month they are $339 and $249
- The Terms of Service name no company, no LLC and no address, and state availability is confirmed only during the intake
- The $50 lab fee sits in a "how it works" step rather than in the pricing table
Featured provider
MadeMed
MadeMed scores 80.4/100 (B−). MadeMed advertises all-dose pricing across 30-, 90- and 360-day purchases, with a consultation-fee conflict to resolve before prepaying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.